Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115757) titled 'An observational study on the use of chromosomal instability detection for predicting tumor recurrence and prognosis' on Dec. 30, 2025.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Tianjin First Central Hospital

Condition: Advanced malignant tumor

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-12-30

Target Sample Size: Observational group:100;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=299816

Disclaimer: Curated by HT Syndication....